Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Functional Genome/Proteomic Analysis of Pathogen-Host Interactions
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort.
Longevity is associated with increased vascular resistance to high glucose-induced oxidative stress and inflammatory gene expression in Peromyscus leucopus.
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. J Clin Pharm Ther. 2019 Apr; 44(2):220-228.
View in:
PubMed
subject areas
Administration, Oral
Aged
Aged, 80 and over
Anti-Bacterial Agents
Clostridium Infections
Female
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Recurrence
Retrospective Studies
Treatment Failure
Treatment Outcome
Vancomycin
authors with profiles
Grant H Skrepnek